{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:13:19Z","timestamp":1789132399711,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003945","name":"Link\u00f6ping University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003945","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Obstructive sleep apnoea is a common yet frequently underdiagnosed condition in patients with type 2 diabetes, particularly in primary care. Early detection is important, as untreated sleep apnoea may contribute to worsened metabolic control and increased cardiovascular risk. This study evaluated 164 patients with type 2 diabetes and found that 75% had obstructive sleep apnoea, with 31% requiring treatment for moderate to severe cases. Predicting obstructive sleep apnoea for which medical treatment is indicated (i.e., moderate to severe OSA) proved challenging, as typical clinical symptoms and most other readily available clinical parameters proved to be unreliable indicators. However, central fat distribution, indicated by a higher waist-to-hip ratio (odds ratio 3.31, 95% confidence interval 1.91\u20136.25, <jats:italic>p<\/jats:italic>\u2009=\u20090.0032), and the presence of albuminuria (odds ratio 7.46, 95% confidence interval 1.99\u201327.89, <jats:italic>p<\/jats:italic>\u2009=\u20090.0244), emerged as significant predictors, with albuminuria representing a novel finding. Screening tools such as the STOP-Bang questionnaire had limited predictive accuracy. These findings highlight the importance of targeted screening in patients with type 2 diabetes, particularly those with central fat distribution or albuminuria, to reduce underdiagnosis and potentially improve treatment outcomes.<\/jats:p>","DOI":"10.1038\/s41598-025-93362-1","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:57:16Z","timestamp":1741856236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinically available predictors of obstructive sleep apnoea requiring treatment in type 2 diabetes patients in primary care"],"prefix":"10.1038","volume":"15","author":[{"given":"Jonas","family":"Agholme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Ahtola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebba","family":"Toll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Johan","family":"Carlh\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Henriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios","family":"Kechagias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Sysoev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Wijkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Ekstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ulander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4245-7565","authenticated-orcid":false,"given":"Fredrik","family":"Iredahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"93362_CR1","doi-asserted-by":"publisher","first-page":"e001071","DOI":"10.1136\/bmjdrc-2019-001071","volume":"8","author":"B Carstensen","year":"2020","unstructured":"Carstensen, B. & R\u00f8nn, P. F. J\u00f8rgensen ME (2020) Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996\u20132016. BMJ Open Diabetes Res. Care 8, e001071 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"93362_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1403494820951004","volume":"50","author":"KB Sl\u00e5tsve","year":"2022","unstructured":"Sl\u00e5tsve, K. B. et al. The total prevalence of diagnosed diabetes and the quality of diabetes care for the adult population in Salten, Norway. Scand. J. Public Health 50, 161\u2013171 (2022).","journal-title":"Scand. J. Public Health"},{"key":"93362_CR3","volume":"16","author":"AS Veyhe","year":"2019","unstructured":"Veyhe, A. S. et al. Prevalence of prediabetes and type 2 diabetes in two non-random populations aged 44\u201377 years in the Faroe Islands. J. Clin. Transl. Endocrinol. 16, 100187 (2019).","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"93362_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"93362_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1185\/03007995.2016.1168291","volume":"32","author":"K Iglay","year":"2016","unstructured":"Iglay, K. et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr. Med. Res. Opin. 32, 1243\u20131252 (2016).","journal-title":"Curr. Med. Res. Opin."},{"key":"93362_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia, M. J. International classification of sleep disorders-third edition: Highlights and modifications. Chest 146, 1387\u20131394 (2014).","journal-title":"Chest"},{"key":"93362_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.chest.2023.03.010","volume":"164","author":"G Baldanzi","year":"2023","unstructured":"Baldanzi, G. et al. OSA is associated with the human gut microbiota composition and functional potential in the population-based Swedish cardiopulmonary bioimage study. CHEST 164, 503\u2013516 (2023).","journal-title":"CHEST"},{"key":"93362_CR8","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1378\/chest.11-1945","volume":"141","author":"JE Heffner","year":"2012","unstructured":"Heffner, J. E., Rozenfeld, Y., Kai, M., Stephens, E. A. & Brown, L. K. Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care. Chest 141, 1414\u20131421 (2012).","journal-title":"Chest"},{"key":"93362_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11892-018-1055-8","volume":"18","author":"RP Ogilvie","year":"2018","unstructured":"Ogilvie, R. P. & Patel, S. R. The epidemiology of sleep and diabetes. Curr. Diab. Rep. 18, 82 (2018).","journal-title":"Curr. Diab. Rep."},{"key":"93362_CR10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/alr.23079","volume":"13","author":"JL Chang","year":"2023","unstructured":"Chang, J. L. et al. International consensus statement on obstructive sleep apnea. Int. Forum Allergy Rhinol. 13, 1061\u20131482 (2023).","journal-title":"Int. Forum Allergy Rhinol."},{"key":"93362_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2337\/dc18-2004","volume":"42","author":"A Subramanian","year":"2019","unstructured":"Subramanian, A. et al. Risk of incident obstructive sleep apnea among patients With Type 2 diabetes. Diabetes Care 42, 954\u2013963 (2019).","journal-title":"Diabetes Care"},{"key":"93362_CR12","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1378\/chest.13-2403","volume":"146","author":"BD Kent","year":"2014","unstructured":"Kent, B. D. et al. Diabetes mellitus prevalence and control in sleep-disordered breathing: The European Sleep Apnea Cohort (ESADA) study. Chest 146, 982\u2013990 (2014).","journal-title":"Chest"},{"key":"93362_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fendo.2018.00440","volume":"9","author":"SN Framnes","year":"2018","unstructured":"Framnes, S. N. & Arble, D. M. The bidirectional relationship between obstructive sleep apnea and metabolic disease. Front. Endocrinol. 9, 440 (2018).","journal-title":"Front. Endocrinol."},{"key":"93362_CR14","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc15-S006","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. 3. Initial evaluation and diabetes management planning. Diabetes Care 38, S17\u2013S19 (2015).","journal-title":"Diabetes Care"},{"key":"93362_CR15","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","volume":"65","author":"MJ Davies","year":"2022","unstructured":"Davies, M. J. et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 65, 1925\u20131966 (2022).","journal-title":"Diabetologia"},{"key":"93362_CR16","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.3390\/nu14234989","volume":"14","author":"SA Paschou","year":"2022","unstructured":"Paschou, S. A. et al. Sleep apnea and cardiovascular risk in patients with prediabetes and type 2 diabetes. Nutrients 14, 4989 (2022).","journal-title":"Nutrients"},{"key":"93362_CR17","unstructured":"International Diabetes Federation. The IDF consensus statement on sleep apnoea and type 2 diabetes. (2008)."},{"key":"93362_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s13410-020-00909-1","volume":"41","author":"V Viswanathan","year":"2021","unstructured":"Viswanathan, V., Ramakrishnan, N., Saboo, B. & Agarwal, S. RSSDI clinical practice recommendations for screening, diagnosis, and treatment in type 2 diabetes mellitus with obstructive sleep apnea. Int. J. Diabetes Dev. Ctries. 41, 4\u201321 (2021).","journal-title":"Int. J. Diabetes Dev. Ctries."},{"key":"93362_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.sleep.2016.07.009","volume":"26","author":"K Westlake","year":"2016","unstructured":"Westlake, K., Plihalova, A., Pretl, M., Lattova, Z. & Polak, J. Screening for obstructive sleep apnea syndrome in patients with type 2 diabetes mellitus: A prospective study on sensitivity of Berlin and STOP-Bang questionnaires. Sleep Med. 26, 71\u201376 (2016).","journal-title":"Sleep Med."},{"key":"93362_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.diabres.2017.10.013","volume":"134","author":"LM Donovan","year":"2017","unstructured":"Donovan, L. M. et al. The effectiveness of an obstructive sleep apnea screening and treatment program in patients with type 2 diabetes. Diabetes Res. Clin. Pract. 134, 145\u2013152 (2017).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"93362_CR21","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.nurpra.2022.02.020","volume":"18","author":"HB Morrison","year":"2022","unstructured":"Morrison, H. B., Padilla, B. I., Thompson, J. A. & Kreider, K. E. Obstructive sleep apnea and type 2 diabetes: A screening approach. J. Nurse Pract. 18, 580\u2013582 (2022).","journal-title":"J. Nurse Pract."},{"key":"93362_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.sleep.2018.12.017","volume":"62","author":"R Abud","year":"2019","unstructured":"Abud, R. et al. Efficacy of continuous positive airway pressure (CPAP) preventing type 2 diabetes mellitus in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and insulin resistance: A systematic review and meta-analysis. Sleep Med. 62, 14\u201321 (2019).","journal-title":"Sleep Med."},{"key":"93362_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1001\/jama.2016.19635","volume":"317","author":"DE Jonas","year":"2017","unstructured":"Jonas, D. E. et al. Screening for obstructive sleep apnea in adults: Evidence report and systematic review for the US preventive services task force. JAMA 317, 415 (2017).","journal-title":"JAMA"},{"key":"93362_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12876-021-01763-z","volume":"21","author":"P Nasr","year":"2021","unstructured":"Nasr, P. et al. Evaluating the prevalence and severity of NAFLD in primary care: The EPSONIP study protocol. BMC Gastroenterol. 21, 180 (2021).","journal-title":"BMC Gastroenterol."},{"key":"93362_CR25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns, M. W. A new method for measuring daytime sleepiness: The epworth sleepiness scale. Sleep 14, 540\u2013545 (1991).","journal-title":"Sleep"},{"key":"93362_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R. & Kupfer, D. J. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 28, 193\u2013213 (1989).","journal-title":"Psychiatry Res."},{"key":"93362_CR27","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/ALN.0b013e31816d83e4","volume":"108","author":"F Chung","year":"2008","unstructured":"Chung, F. et al. STOP questionnaire: A tool to screen patients for obstructive sleep apnea. Anesthesiology 108, 812\u2013821 (2008).","journal-title":"Anesthesiology"},{"key":"93362_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley, J. A. & McNeil, B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29\u201336 (1982).","journal-title":"Radiology"},{"key":"93362_CR29","doi-asserted-by":"crossref","unstructured":"Buuren, S. V. & Groothuis-Oudshoorn, K. Mice\u202f: Multivariate imputation by chained equations in R. J. Stat. Softw. 45, (2011).","DOI":"10.18637\/jss.v045.i03"},{"key":"93362_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41512-018-0037-2","volume":"2","author":"NR Cook","year":"2018","unstructured":"Cook, N. R. Quantifying the added value of new biomarkers: How and how not. Diagn. Progn. Res. 2, 14 (2018).","journal-title":"Diagn. Progn. Res."},{"key":"93362_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/jsr.12088","volume":"23","author":"E Mazzuca","year":"2014","unstructured":"Mazzuca, E. et al. Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea. J. Sleep Res. 23, 13\u201321 (2014).","journal-title":"J. Sleep Res."},{"key":"93362_CR32","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1164\/rccm.200209-1055OC","volume":"167","author":"T Young","year":"2003","unstructured":"Young, T., Finn, L., Austin, D. & Peterson, A. Menopausal status and sleep-disordered breathing in the Wisconsin sleep cohort study. Am. J. Respir. Crit. Care Med. 167, 1181\u20131185 (2003).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"93362_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ajog.2019.04.023","volume":"221","author":"A Ambikairajah","year":"2019","unstructured":"Ambikairajah, A., Walsh, E., Tabatabaei-Jafari, H. & Cherbuin, N. Fat mass changes during menopause: A metaanalysis. Am. J. Obstet. Gynecol. 221, 393-409.e50 (2019).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"93362_CR34","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1038\/s41598-021-85023-w","volume":"11","author":"E Zamarr\u00f3n","year":"2021","unstructured":"Zamarr\u00f3n, E. et al. Obstructive sleep apnea is associated with impaired renal function in patients with diabetic kidney disease. Sci. Rep. 11, 5675 (2021).","journal-title":"Sci. Rep."},{"key":"93362_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.chest.2019.09.004","volume":"157","author":"C-H Lin","year":"2020","unstructured":"Lin, C.-H., Lurie, R. C. & Lyons, O. D. Sleep apnea and chronic kidney disease: A state-of-the-art review. Chest 157, 673\u2013685 (2020).","journal-title":"Chest"},{"key":"93362_CR36","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s11255-020-02699-1","volume":"53","author":"P Hansrivijit","year":"2021","unstructured":"Hansrivijit, P., Puthenpura, M. M., Ghahramani, N., Thongprayoon, C. & Cheungpasitporn, W. Bidirectional association between chronic kidney disease and sleep apnea: A systematic review and meta-analysis. Int. Urol. Nephrol. 53, 1209\u20131222 (2021).","journal-title":"Int. Urol. Nephrol."},{"key":"93362_CR37","doi-asserted-by":"publisher","first-page":"971","DOI":"10.5114\/aoms.2018.73984","volume":"14","author":"Y Teng","year":"2018","unstructured":"Teng, Y., Wang, S., Wang, N. & Li, M. STOP-Bang questionnaire screening for obstructive sleep apnea among Chinese patients with type 2 diabetes mellitus. Arch. Med. Sci. AMS 14, 971\u2013978 (2018).","journal-title":"Arch. Med. Sci. AMS"},{"key":"93362_CR38","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s11325-021-02450-9","volume":"26","author":"L Bernhardt","year":"2022","unstructured":"Bernhardt, L. et al. Diagnostic accuracy of screening questionnaires for obstructive sleep apnoea in adults in different clinical cohorts: A systematic review and meta-analysis. Sleep Breath. 26, 1053\u20131078 (2022).","journal-title":"Sleep Breath."},{"key":"93362_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s11325-011-0578-x","volume":"16","author":"R Pecotic","year":"2012","unstructured":"Pecotic, R., Dodig, I. P., Valic, M., Ivkovic, N. & Dogas, Z. The evaluation of the Croatian version of the Epworth sleepiness scale and STOP questionnaire as screening tools for obstructive sleep apnea syndrome. Sleep Breath. 16, 793\u2013802 (2012).","journal-title":"Sleep Breath."},{"key":"93362_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0022-3999(00)00186-0","volume":"49","author":"KF Chung","year":"2000","unstructured":"Chung, K. F. Use of the Epworth sleepiness scale in Chinese patients with obstructive sleep apnea and normal hospital employees. J. Psychosom. Res. 49, 367\u2013372 (2000).","journal-title":"J. Psychosom. Res."},{"key":"93362_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5694\/mja2.50145","volume":"211","author":"CV Senaratna","year":"2019","unstructured":"Senaratna, C. V. et al. Detecting sleep apnoea syndrome in primary care with screening questionnaires and the Epworth sleepiness scale. Med. J. Aust. 211, 65\u201370 (2019).","journal-title":"Med. J. Aust."},{"key":"93362_CR42","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5665\/sleep.4488","volume":"38","author":"J Fernandez-Mendoza","year":"2015","unstructured":"Fernandez-Mendoza, J. et al. Natural history of excessive daytime sleepiness: Role of obesity, weight loss, depression, and sleep propensity. Sleep 38, 351\u2013360 (2015).","journal-title":"Sleep"},{"key":"93362_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1164\/rccm.201808-1509OC","volume":"200","author":"DR Mazzotti","year":"2019","unstructured":"Mazzotti, D. R. et al. Symptom subtypes of obstructive sleep apnea predict incidence of cardiovascular outcomes. Am. J. Respir. Crit. Care Med. 200, 493\u2013506 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"93362_CR44","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.21037\/atm-20-6890","volume":"8","author":"H Shi","year":"2020","unstructured":"Shi, H. et al. Development and validation of a nomogram for predicting the risk of obstructive sleep apnea in patients with type 2 diabetes. Ann. Transl. Med. 8, 1675\u20131675 (2020).","journal-title":"Ann. Transl. Med."},{"key":"93362_CR45","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1606599","volume":"375","author":"RD McEvoy","year":"2016","unstructured":"McEvoy, R. D. et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N. Engl. J. Med. 375, 919\u2013931 (2016).","journal-title":"N. Engl. J. Med."},{"key":"93362_CR46","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.5664\/jcsm.10740","volume":"19","author":"D Yang","year":"2023","unstructured":"Yang, D., Li, L., Dong, J., Yang, W. & Liu, Z. Effects of continuous positive airway pressure on cardiac events and metabolic components in patients with moderate to severe obstructive sleep apnea and coronary artery disease: A meta-analysis. J. Clin. Sleep Med. 19, 2015\u20132025 (2023).","journal-title":"J. Clin. Sleep Med."},{"key":"93362_CR47","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3389\/fendo.2018.00714","volume":"9","author":"K Westlake","year":"2018","unstructured":"Westlake, K., Dostalova, V., Plihalova, A., Pretl, M. & Polak, J. The clinical impact of systematic screening for obstructive sleep apnea in a type 2 diabetes population\u2014Adherence to the screening-diagnostic process and the acceptance and adherence to the CPAP therapy compared to regular sleep clinic patients. Front. Endocrinol. 9, 714 (2018).","journal-title":"Front. Endocrinol."},{"key":"93362_CR48","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2337\/dc08-1776","volume":"32","author":"GD Foster","year":"2009","unstructured":"Foster, G. D. et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 32, 1017\u20131019 (2009).","journal-title":"Diabetes Care"},{"key":"93362_CR49","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2337\/diacare.26.3.702","volume":"26","author":"HE Resnick","year":"2003","unstructured":"Resnick, H. E. et al. Diabetes and sleep disturbances: Findings from the Sleep Heart Health Study. Diabetes Care 26, 702\u2013709 (2003).","journal-title":"Diabetes Care"},{"key":"93362_CR50","doi-asserted-by":"publisher","first-page":"583","DOI":"10.5664\/jcsm.6548","volume":"13","author":"A Amin","year":"2017","unstructured":"Amin, A. et al. Prevalence and associations of obstructive sleep apnea in South Asians and White Europeans with type 2 diabetes: A cross-sectional study. J. Clin. Sleep Med. 13, 583\u2013589 (2017).","journal-title":"J. Clin. Sleep Med."},{"key":"93362_CR51","doi-asserted-by":"publisher","first-page":"853","DOI":"10.5664\/jcsm.2978","volume":"09","author":"WB Leong","year":"2013","unstructured":"Leong, W. B. et al. The prevalence and severity of obstructive sleep apnea in severe obesity: The impact of ethnicity. J. Clin. Sleep Med. 09, 853\u2013858 (2013).","journal-title":"J. Clin. Sleep Med."},{"key":"93362_CR52","unstructured":"Ejnell, H. et al. National guidelines for the investigation of suspected sleep apnea in adults [Nationella riktlinjer f\u00f6r utredning av misst\u00e4nkt s\u00f6mnapn\u00e9 hos vuxna]. (Swedish Sleep Apnea Registry (SESAR), 2018)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93362-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93362-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93362-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T09:56:29Z","timestamp":1757152589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93362-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93362"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93362-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the license information.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JA has received speaker fees from AstraZeneca. MW has served on advisory boards or lectured for MSD, Lilly, Novo Nordisk, and Sanofi, and organized a professional regional meeting sponsored by Lilly, Rubin Medical, Sanofi, Novartis, and Novo Nordisk. ME has served on advisory boards for AMRA Medical and Novo Nordisk. FI has received speaker fees and served on advisory boards for Novo Nordisk, Sanofi, and Boehringer Ingelheim. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8710"}}